a-PPP
Well-documented
Well-documented
Multiple authoritative sources agree on dosing and effects.
- 3 corroborating sources
- 5 ROAs with full dose ladders
- duration data present
- 18 combo interactions documented
- classified Research-chemical
- 3 corroborating sources
- 5 ROAs with full dose ladders
- duration data present
- 18 combo interactions documented
- classified Research-chemical
Aliases: Ppp
Summary
Ξ±-PPP is the three-carbon homologue in the pyrrolidinophenone series (shorter alkyl chain than Ξ±-PVP and Ξ±-PBP). It acts as a potent DAT and NET inhibitor with negligible SERT activity, but uniquely also functions as a partial norepinephrine releasing agent and 5-HT2A antagonistβproperties not shared by Ξ±-PVP. This 5-HT2A antagonism may contribute to its reportedly lower euphoria and reduced popularity compared to Ξ±-PVP.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 15-30mg | 30-60mg | 60-90mg | 90mg+ |
| Sublingual | 15-30mg | 30-50mg | 50-80mg | 80mg+ |
| Insufflated | 10-20mg | 20-40mg | 40-70mg | 70mg+ |
| Vaporized | 5-10mg | 10-25mg | 25-40mg | 40mg+ |
| Intravenous | 25-50mg | 50-100mg | 100-150mg | 150mg+ |
Onset, Duration & After-effects
| ROA | Onset | Peak | Offset | Total |
|---|---|---|---|---|
| Oral | 15-45 min | 0.5-2 hrs | 1-2 hrs | 3-6 hrs |
| Sublingual | - | 0.5-2 hrs | 1-2 hrs | 3-6 hrs |
| Insufflated | 5-15 min | 0.5-2 hrs | 1-2 hrs | 3-6 hrs |
| Vaporized | 1-2 min | 0.5-2 hrs | 1-2 hrs | 3-6 hrs |
| Intravenous | - | 0.5-2 hrs | 1-2 hrs | 3-6 hrs |
Effect Profile
Scores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Strong anxiety/jitters with moderate euphoria and focus, mild stimulation
Tolerance
Tolerance Decay
Acute tolerance: develops within a single session β the reset numbers above apply after sustained heavy use, not after one binge. Within-session tachyphylaxis usually resets largely overnight.
Pattern based on user reports for shortβacting pyrrolidinophenones; high interindividual variability. Conservative spacing of sessions (β₯7 days) reduces escalation and crash severity.
Cross-Tolerances
Effects
- Stimulation
- Vasoconstriction
- Bruxism
- Tachycardia
- Temperature regulation suppression
- Increased heart rate
- Teeth grinding
- Insomnia
- Increased blood pressure
- Increased perspiration
- Focus enhancement
- Motivation enhancement
- Increased sociability
- Wakefulness
- Euphoria
- Cognitive euphoria
- Anxiety
- Compulsive redosing
- Paranoia
- Thought acceleration
- Increased libido
- Tactile enhancement
- Increased music appreciation
- Appetite suppression
- Light sensitivity
- Dehydration
- Disinhibition
- Appetite Suppression
- Vibrating vision
- Increase sexuality
Combinations
Cross-Check a-PPP with another substanceHelpful Links
Report an issue or suggest an edit
Spotted incorrect or dangerous information, have a correction, a new study, or a useful addition for a-PPP? Let us know. Reports are reviewed by moderators — this is not posted publicly.